Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision updated to version v3.5.4, replacing the previous v3.5.3; this indicates an administrative update to the page content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, representing a small metadata/versioning change on the page rather than a substantive alteration to the study information.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check52 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. The previous revision was removed.SummaryDifference0.0%

- Check67 days agoChange Detected- Page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision: v3.4.2 replaces the previous Revision: v3.4.1 on the page. This update appears to be a site version change with no evident impact on the study details or user actions.SummaryDifference0.0%

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.